enzon inc said new treatment using its investigational new drug peg ada has restored functioning immune system first two children were born deficient enzyme adenosine deaminase disorder known severe combined immunodeficiency disease bubble boy disease bubble boy disease rare but severe disease hampers development immune system has killed most its victims before adulthood children with disease consigned live sterile environment such plastic bubble avoid infection company said study enzon drug conducted duke university showed two children suffering from disease were treated for and seven months respectively and were free serious infection during time company said results were published new england journal medicine disease caused missing enzyme called adenosine deaminase ada crucial development immune system enzon said has developed technology coat enzyme with substance called polyethylene glycol peg serving disguise enzyme when reintroduced into body preventing rejection marked improvement laboratory tests immune function occurred each child along with increase number lymphocytes immune cells were missing before treatment with peg ada had begun study said children now more active and have begun gain weight and height before treatment growth had been very poor comparison normal children same age study conducted doctors michael hershfield and rebecca buckley said peg ada injections were given once week victims disease have traditionally been treated bone marrow transplants but for most donors not available transplantation unsuccessful company said diseases caused missing enzyme might also treated introducing peg coated enzyme article noted reuter 